Access cutting-edge lung cancer treatment through this clinical trial at a research site in Fullerton. Study-provided care at no cost to qualified participants.
Access lung cancer specialists in Fullerton at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer treatment provided free
The purpose of this study is to evaluate whether enhanced dermatologic management can reduce incidence of grade greater than or equal to (\>=) 2 dermatologic adverse events of interest (DAEIs) when compared with standard-of-care skin management and with modified enhanced dermatologic management in participants with locally advanced or metastatic stage IIIB/C-IV epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) treated first-line with amivantamab and lazertinib. T
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this lung cancer clinical trial in Fullerton, CA
If you're searching for lung cancer treatment options in Fullerton, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fullerton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.